Dramatic Effect of Rituximab in Immunoglobulin G4-Related Primary Sclerosing Cholangitis

MLA

Hanisha Manickavasagan, et al. “Dramatic Effect of Rituximab in Immunoglobulin G4-Related Primary Sclerosing Cholangitis.” American Journal of Gastroenterology, vol. 111, Oct. 2016, pp. S586–87. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b17bb4a49f8b2d6d68db85b45d533640&authtype=sso&custid=ns315887.

APA

Hanisha Manickavasagan, Robert Wood, Scott Kindsfather, & Santiago J. Munoz. (2016). Dramatic Effect of Rituximab in Immunoglobulin G4-Related Primary Sclerosing Cholangitis. American Journal of Gastroenterology, 111, S586–S587.

Chicago

Hanisha Manickavasagan, Robert Wood, Scott Kindsfather, and Santiago J. Munoz. 2016. “Dramatic Effect of Rituximab in Immunoglobulin G4-Related Primary Sclerosing Cholangitis.” American Journal of Gastroenterology 111 (October): S586–87. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b17bb4a49f8b2d6d68db85b45d533640&authtype=sso&custid=ns315887.